B lymphocyte proliferation is suppressed by the opioid growth factor–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases-Reference-Cited by-同舟云学术

B lymphocyte proliferation is suppressed by the opioid growth factor–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases

Published:2011-01 Issue:1-2 Volume:216 Page:173-183
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Zagon Ian S.,Donahue Renee N.,Bonneau Robert H.,McLaughlin Patricia J.

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference61 articles.

1. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy;Adamus;Autoimmun. Rev.,2009

2. Endogenous opioids: biology and function;Akil;Ann. Rev. Neurosci.,1984

3. Understanding autoimmune disease: new targets for drug discovery;Balague;Drug Discov. Today,2009

4. Regulation of proenkephalin A messenger ribonucleic acid levels in normal B lymphocytes: specific inhibition by glucocorticoid hormones and superinduction by cycloheximide;Behar;Endocrinology,1991

5. Opioid growth factor modulates angiogenesis;Blebea;J. Vascular Surg.,2000

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss-of-function OGFRL1 variants identified in autosomal recessive cherubism families;JBMR Plus;2024-04-09

2. Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy;Cancers;2024-03-21

3. Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial;Anesthesiology;2021-09-09

4. Research Progress on the Mechanism of the Acupuncture Regulating Neuro-Endocrine-Immune Network System;Veterinary Sciences;2021-07-30

5. Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy;International Immunopharmacology;2021-07